Abstract:The advancement of nanobiotechnology has led to the development of various techniques for addressing target-specific drug delivery issues. In this article, we successfully developed a supramolecular self-assembly approach for the fabrication of polyacrylate-based nanoparticles with simultaneous loading of the anticancer drug doxorubicin (DOX) for targeted delivery towards cancer treatment in vitro and in vivo. Two types of polyacrylates functionalized with adamantane and β-cyclodextrin respectively could self-assemble to form supramolecular nanoparticles through strong host-guest complexation between adamantane and β-cyclodextrin. Folic acid was incorporated within the supramolecular nanoparticles in order to impart the targeting specificity towards selected cancerous cell lines, namely MDA-MB231 and B16-F10. The as-synthesized supramolecular nanoparticles were fully characterized by several techniques, revealing an average nanoparticle size of 35 nm in diameter, which is small enough for excellent blood circulation. The cytotoxicity studies indicate that the supramolecular nanoparticles without drug loading were non-cytotoxic under the concentrations measured, while DOX-loaded supramolecular nanoparticles showed significant cytotoxicity. In order to investigate the targeting specificity of DOX-loaded supramolecular nanoparticles towards the cancerous cells, a healthy cell line model HEK293 was employed for carrying out the comparison studies. Due to the presence of the targeting ligand, experimental results demonstrate that the supramolecular nanoparticles were highly specific for targeting the cancerous cells, but not for HEK293 cells. After the in vitro investigations, the in vivo drug delivery study using DOX-loaded supramolecular nanoparticles was performed. Tumor-bearing nude mice were treated with DOX-loaded supramolecular nanoparticles, and the analysis results indicate that DOX-loaded supramolecular nanoparticles have the capability to enhance the therapeutic effects of DOX for effectively inhibiting the tumor growth. Thus, the self-assembled polymeric nanoparticles exhibit a highly promising potential to serve as drug carriers for targeted drug delivery towards improved cancer treatment.

Drug loading properties,cell uptake and cytotoxicity of new peptide polyamidoamine targeting drug carrier

Novel Peptide-Dendrimer Conjugates As Drug Carriers for Targeting Nonsmall Cell Lung Cancer.

Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.

Construction and Evaluation of PAMAM–DOX Conjugates with Superior Tumor Recognition and Intracellular Acid-Triggered Drug Release Properties

Construction and Antitumor Properties of a Targeted Nano-drug Carrier System Responsive to the Tumor Microenvironment.

Targeted and Ph-Responsive Delivery of Doxorubicin to Cancer Cells Using Multifunctional Dendrimer-Modified Multi-Walled Carbon Nanotubes

Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated Ph-Dependent Thermo-Sensitive Copolymer: in Vitro and in Vivo Evaluation

Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug delivery.

Folic Acid-Targeted Polydopamine-Based Surface Modification of Mesoporous Silica Nanoparticles As Delivery Vehicles for Cancer Therapy

Highly Effective Drug Delivery and Cell Imaging Using Fluorescent Double-Imprinted Nanoparticles by Targeting Recognition of the Epitope of Membrane Protein.

Nanoscaled Poly(l-Glutamic Acid)/doxorubicin-Amphiphile Complex As Ph-Responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer.

Aptamer-Anchored Di-Polymer Shell-Capped Mesoporous Carbon As A Drug Carrier for Bi-Trigger Targeted Drug Delivery

Crgd-Modified Benzimidazole-based Ph-Responsive Nanoparticles for Enhanced Tumor Targeted Doxorubicin Delivery.

Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells.

Synthesis and Characterization of A Poly(Amido Amine) Modified Magnetic Nanocarrier for Controlled Delivery of Doxorubicin

Tumor-Acidity Activated Surface Charge-Conversion of Polymeric Nanocarriers for Enhanced Cell Adhesion and Targeted Drug Release

Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles.

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Drug–carrier Interaction Analysis in the Cell Penetrating Peptide-Modified Liposomes for Doxorubicin Loading

Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.

Novel Ph-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized Β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.